Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone and Ramipril for Diabetic Vasculopathy
NCT00489229Phase 3Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone, ramipril in type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), sponsored by Universiti Sains Malaysia. Started Oct 2002; status: completed.
02
Drugs
rosiglitazoneramipril
03
Conditions
type 2 diabetes mellitus (T2DM)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00489229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489229.